| 000 | 00923 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517194119.0 | ||
| 264 | 0 | _c20180112 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 024 | 7 |
_a10.1056/NEJMc1714810 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSong, Gwan G | |
| 245 | 0 | 0 |
_aRomosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _c01 2018 |
||
| 300 |
_a194 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAlendronate |
| 650 | 0 | 4 | _aAntibodies, Monoclonal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFractures, Bone |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aOsteoporosis |
| 700 | 1 | _aLee, Young H | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 378 _gno. 2 _gp. 194 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMc1714810 _zAvailable from publisher's website |
| 999 |
_c27969006 _d27969006 |
||